Teleflex Incorporated $TFX Shares Sold by Legal & General Group Plc

Posted by Stanley Muller on Jun 3rd, 2026

Legal & General Group Plc reduced its stake in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 15.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 113,797 shares of the medical technology company’s stock after selling 20,554 shares during the quarter. Legal & General Group Plc owned 0.26% of Teleflex worth $13,888,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the stock. Banque Cantonale Vaudoise raised its position in Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after acquiring an additional 113 shares in the last quarter. Hantz Financial Services Inc. raised its position in Teleflex by 40.5% during the fourth quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock valued at $48,000 after acquiring an additional 113 shares in the last quarter. Fifth Third Bancorp raised its position in Teleflex by 7.8% during the third quarter. Fifth Third Bancorp now owns 2,083 shares of the medical technology company’s stock valued at $255,000 after acquiring an additional 151 shares in the last quarter. Oregon Public Employees Retirement Fund raised its position in Teleflex by 1.7% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 10,114 shares of the medical technology company’s stock valued at $1,234,000 after acquiring an additional 167 shares in the last quarter. Finally, Osaic Holdings Inc. raised its position in Teleflex by 17.5% during the second quarter. Osaic Holdings Inc. now owns 1,247 shares of the medical technology company’s stock valued at $148,000 after acquiring an additional 186 shares in the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

TFX has been the subject of several recent research reports. Bank of America upgraded Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target for the company in a research report on Monday, April 13th. Mizuho set a $140.00 price target on Teleflex in a research report on Friday, May 8th. Wells Fargo & Company lifted their price target on Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. Needham & Company LLC lifted their price target on Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a research report on Thursday, February 26th. Finally, Truist Financial reiterated a “hold” rating and set a $143.00 price target (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. Three analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Teleflex presently has an average rating of “Hold” and an average price target of $144.00.

Read Our Latest Stock Report on Teleflex

Teleflex Stock Down 1.8%

Shares of TFX opened at $125.29 on Wednesday. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. Teleflex Incorporated has a 12 month low of $100.18 and a 12 month high of $139.67. The stock’s 50 day moving average is $125.28 and its two-hundred day moving average is $117.54. The firm has a market cap of $5.55 billion, a P/E ratio of -5.50, a PEG ratio of 0.95 and a beta of 0.82.

Teleflex (NYSE:TFX – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. During the same period last year, the company earned $1.44 earnings per share. Teleflex’s quarterly revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Analysts predict that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Friday, May 22nd. Teleflex’s dividend payout ratio (DPR) is presently -5.96%.

Teleflex Profile

(Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.